Cargando…

Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk

BACKGROUND: Loss-of-function mutations in the SGLT1 (sodium/glucose co-transporter-1) gene result in a rare glucose/galactose malabsorption disorder and neonatal death if untreated. In the general population, variants related to intestinal glucose absorption remain uncharacterized. OBJECTIVES: The g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seidelmann, Sara B., Feofanova, Elena, Yu, Bing, Franceschini, Nora, Claggett, Brian, Kuokkanen, Mikko, Puolijoki, Hannu, Ebeling, Tapani, Perola, Markus, Salomaa, Veikko, Shah, Amil, Coresh, Josef, Selvin, Elizabeth, MacRae, Calum A., Cheng, Susan, Boerwinkle, Eric, Solomon, Scott D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403489/ https://www.ncbi.nlm.nih.gov/pubmed/30286918 http://dx.doi.org/10.1016/j.jacc.2018.07.061

Ejemplares similares

An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
por: Seidelmann, Sara B., et al.
Publicado: (2017)

Population-level effects of the national diabetes prevention programme (FIN-D2D) on the body weight, the waist circumference, and the prevalence of obesity
por: Salopuro, Titta M, et al.
Publicado: (2011)

Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis
por: Seidelmann, Sara B, et al.
Publicado: (2018)

Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study
por: Gupta, Deepak K, et al.
Publicado: (2015)

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study
por: Wijkman, Magnus O., et al.
Publicado: (2021)

Parsing cell death in arrhythmogenic cardiomyopathy: PANoptosis
por: MacRae, Calum A.
Publicado: (2023)

Bayesian Variable Selection in Searching for Additive and Dominant Effects in Genome-Wide Data
por: Peltola, Tomi, et al.
Publicado: (2012)

Genetic causal beliefs about morbidity: associations with health behaviors and health outcome beliefs about behavior changes between 1982–2002 in the Finnish population
por: Haukkala, Ari, et al.
Publicado: (2015)

Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome
por: Pruett, Jacob E., et al.
Publicado: (2021)

SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study
por: Xu, Min, et al.
Publicado: (2022)

Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome
por: Parkkonen, Olavi, et al.
Publicado: (2017)

Serum metabolomic signatures of plant-based diets and incident chronic kidney disease
por: Kim, Hyunju, et al.
Publicado: (2022)

Cardiac Structure and Function and Diabetes‐Related Risk of Death or Heart Failure in Older Adults
por: Inciardi, Riccardo M., et al.
Publicado: (2022)

Using Multiple Measures for Quantitative Trait Association Analyses: Application to Estimated Glomerular Filtration Rate (eGFR)
por: Tin, A, et al.
Publicado: (2013)

The developmental basis of adult arrhythmia: atrial fibrillation as a paradigm
por: Kapur, Sunil, et al.
Publicado: (2013)

Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs
por: Kithcart, Aaron, et al.
Publicado: (2017)

Association of Mild Valvular Lesions With Long-term Cardiovascular Outcomes Among Black Adults
por: Matsushita, Kunihiro, et al.
Publicado: (2022)

Targeting Diet Quality at the Workplace: Influence on Cardiometabolic Risk
por: Amil, Samira, et al.
Publicado: (2021)

Response to Comment on: Selvin et al. No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes. Diabetes Care 2013;36:2995–3001
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Combined Effects of Thrombosis Pathway Gene Variants Predict Cardiovascular Events
por: Auro, Kirsi, et al.
Publicado: (2007)

Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use
por: Åberg, Fredrik, et al.
Publicado: (2023)

Response to Comments on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116–2121
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Levels and Change in Galectin‐3 and Association With Cardiovascular Events: The ARIC Study
por: Aguilar, David, et al.
Publicado: (2020)

Association of Depressive Symptoms With Impaired Glucose Regulation, Screen-Detected, and Previously Known Type 2 Diabetes: Findings from the Finnish D2D Survey
por: Mäntyselkä, Pekka, et al.
Publicado: (2011)

SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
por: D'Marco, Luis, et al.
Publicado: (2021)

Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study
por: Maruthur, Nisa M., et al.
Publicado: (2015)

Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study
por: Loomis, Stephanie J., et al.
Publicado: (2019)

The Implementation Science for Genomic Health Translation (INSIGHT) Study in Epilepsy: Protocol for a Learning Health Care System
por: Feofanova, Elena Valeryevna, et al.
Publicado: (2021)

Wnt11 patterns a myocardial electrical gradient via regulation of the L-type Ca(2+) channel
por: Panáková, Daniela, et al.
Publicado: (2010)

Single Cell Biology: Exploring Somatic Cell Behaviors, Competition and Selection in Chronic Disease
por: Zhu, Wandi, et al.
Publicado: (2022)

Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
por: Matsushita, Kunihiro, et al.
Publicado: (2017)

A data-driven medication score predicts 10-year mortality among aging adults
por: Häppölä, Paavo, et al.
Publicado: (2020)

Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
por: Belli, Martina, et al.
Publicado: (2022)

Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study
por: Bryant, Tyler S., et al.
Publicado: (2019)

Gene-Environment Interactions of Circadian-Related Genes for Cardiometabolic Traits
por: Dashti, Hassan S., et al.
Publicado: (2015)

Interaction between the NOS3 Gene and Obesity as a Determinant of Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study
por: Bressler, Jan, et al.
Publicado: (2013)

Pulse oximetry values from 33,080 participants in the Apple Heart & Movement Study
por: Shapiro, Ian, et al.
Publicado: (2023)

Mendelian randomisation analysis of clustered causal effects of body mass on cardiometabolic biomarkers
por: Conde, Susana, et al.
Publicado: (2018)

Serum lipopolysaccharides predict advanced liver disease in the general population
por: Männistö, Ville, et al.
Publicado: (2019)

Comparison of various strategies to define the optimal target population for liver fibrosis screening: A population‐based cohort study
por: Åberg, Fredrik, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7crjd7jomagduo6sfao7j81r8f